Optimizing the Dosing Regimens of Daptomycin Based on the Susceptible Dose-Dependent Breakpoint against Vancomycin-Resistant Enterococci Infection

Daptomycin, a lipopeptide antibiotic, is one of the therapeutic options used for the treatment of vancomycin-resistant enterococci (VRE). Recently, the Clinical and Laboratory Standards Institute (CLSI) M100 30th edition has removed the susceptibility (S) breakpoint for Enterococcus faecium and repl...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antibiotics (Basel)
Hlavní autoři: Santimaleeworagun, Wichai, Changpradub, Dhitiwat, Thunyaharn, Sudaluck, Hemapanpairoa, Jatapat
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6963552/
https://ncbi.nlm.nih.gov/pubmed/31795437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics8040245
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky